Search and treat strategy to eliminate Helicobacter pylori associated ulcer disease.
de Boer
W A
WA
Department of Internal Medicine Ziekenhuis Bernhoven, Oss, the Netherlands and Department of Gastroenterology University Hospital Nijmegen, the Netherlands. W.deboer@Bernhoven.nl
Tytgat
G N
GN
D000328:Adult; D000368:Aged; D000863:Antacids / Q000191:economics / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000191:economics / Q000627:therapeutic use; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D016481:Helicobacter Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D008875:Middle Aged; D018579:Patient Selection; D010818:Practice Patterns, Physicians'
D000863:Antacids; D000900:Anti-Bacterial Agents